Trial intelligence / Profile preview

Metformin in Jordanian Women With PCOS

NCT07759674Phase 4Completed

Sponsor
Jerash University
Start
Jun 2023
Primary completion
Sep 2023
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS), sponsored by Jerash University. Primary endpoints: Change in insulin resistance (HOMA-IR) at 6 months and Change in serum ferritin concentration at 6 months. Started Jun 2023; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT07759674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07759674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call